FierceBiotech 2026年4月15日 Terremoto takes $108M series C to fuel clinical trials of AKT1 inhibitors Terremoto takes $108M series C to fuel clinical trials of AKT1 inhibitors 原文
Information Booth Information Booth German Pavilion (German Federal Ministry for Economic Affairs and Climate Action) 资讯
Information Booth Information Booth German Pavilion (German Federal Ministry for Economic Affairs and Climate Action) 资讯